A novel antiviral formulation inhibits a range of enveloped viruses

References

1. Thormar H, Hilmarsson H. The role of microbicidal lipids in host defense against pathogens and their potential as therapeutic agents. Chem Phys Lipids 2007; 150:1–11 [View Article]
   [Google Scholar]
2. Churchward CP, Alany RG, Snyder LAS. Alternative antimicrobials: the properties of fatty acids and monoglycerides. Crit Rev Microbiol 2018; 44:561–570 [View Article]
   [Google Scholar]
3. Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T. Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother 1987; 31:27–31 [View Article]
   [Google Scholar]
4. Hilmarsson H, Kristmundsdottir T, Thormar H. Virucidal activities of medium- and long-chain fatty alcohols, fatty acids and monoglycerides against herpes simplex virus types 1 and 2: comparison at different pH levels. APMIS 2005; 113:58–65 [View Article]
   [Google Scholar]
5. Dichtelmüller H, Rudnick D, Kloft M. Inactivation of lipid enveloped viruses by octanoic acid treatment of immunoglobulin solution. Biologicals 2002; 30:135–142 [View Article]
   [Google Scholar]
6. Pingen M, Bryden SR, Pondeville E, Schnettler E, Kohl A et al. Host inflammatory response to mosquito bites enhances the severity of arbovirus infection. Immunity 2016; 44:1455–1469 [View Article]
   [Google Scholar]
7. Isaacs CE, Kashyap S, Heird WC, Thormar H. Antiviral and antibacterial lipids in human milk and infant formula feeds. Arch Dis Child 1990; 65:861–864 [View Article]
   [Google Scholar]
8. Kohn A, Gitelman J, Inbar M. Unsaturated free fatty acids inactivate animal enveloped viruses. Arch Virol 1980; 66:301–307 [View Article]
   [Google Scholar]
9. Feederle R, Neuhierl B, Bannert H, Geletneky K, Shannon-Lowe C et al. Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int. J. Cancer 2007; 121:588–594 [View Article]
   [Google Scholar]
10. Scagliarini A, McInnes CJ, Gallina L, Dal Pozzo F, Scagliarini L et al. Antiviral activity of HPMPC (cidofovir) against ORF virus infected lambs. Antiviral Res 2007; 73:169–174 [View Article]
    [Google Scholar]
11. Minson AC, Hodgman TC, Digard P, Hancock DC, Bell SE et al. An analysis of the biological properties of monoclonal antibodies against glycoprotein D of herpes simplex virus and identification of amino acid substitutions that confer resistance to neutralization. Journal of General Virology 1986; 67:1001–1013 [View Article]
    [Google Scholar]
12. Fletcher NF, Humphreys E, Jennings E, Osburn W, Lissauer S et al. Hepatitis C virus infection of cholangiocarcinoma cell lines. J Gen Virol 2015; 96:1380–1388 [View Article]
    [Google Scholar]
13. Broer R, Boson B, Spaan W, Cosset François-Loïc, Corver J. Important role for the transmembrane domain of severe acute respiratory syndrome coronavirus spike protein during entry. J Virol 2006; 80:1302–1310 [View Article]
    [Google Scholar]
14. Hashimoto K, Ono N, Tatsuo H, Minagawa H, Takeda M et al. SLAM (CD150)-independent measles virus entry as revealed by recombinant virus expressing green fluorescent protein. J Virol 2002; 76:6743–6749 [View Article]
    [Google Scholar]
15. Reed LJ MH. A simple method of estimating fifty per cent endpoints. Am J Hygiene 1938; 27:493–497
    [Google Scholar]
16. Delecluse H-J, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W. Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 1998; 95:8245–8250 [View Article]
    [Google Scholar]
17. Shannon-Lowe CD, Neuhierl B, Baldwin G, Rickinson AB, Delecluse H-J. Resting B cells as a transfer vehicle for Epstein-Barr virus infection of epithelial cells. Proc Natl Acad Sci U S A 2006; 103:7065–7070 [View Article]
    [Google Scholar]
18. Shannon-Lowe C, Adland E, Bell AI, Delecluse H-J, Rickinson AB et al. Features distinguishing Epstein-Barr virus infections of epithelial cells and B cells: viral genome expression, genome maintenance, and genome amplification. J Virol 2009; 83:7749–7760 [View Article]
    [Google Scholar]
19. Ren Y, Bell S, Zenner HL, Lau S-YK, Crump CM. Glycoprotein M is important for the efficient incorporation of glycoprotein H–L into herpes simplex virus type 1 particles. J Gen Virol 2012; 93:319–329 [View Article]
    [Google Scholar]
20. Chavali PL, Stojic L, Meredith LW, Joseph N, Nahorski MS et al. Neurodevelopmental protein Musashi-1 interacts with the Zika genome and promotes viral replication. Science 2017; 357:83–88 [View Article]
    [Google Scholar]
21. McInnes CJ, Wood AR, Nettleton PF, Gilray JA. Genomic comparison of an avirulent strain of ORF virus with that of a virulent wild type isolate reveals that the ORF virus G2L gene is non-essential for replication. Virus Genes 2001; 22:141–150 [View Article]
    [Google Scholar]
22. Wobus CE, Karst SM, Thackray LB, Chang K-O, Sosnovtsev SV et al. Replication of norovirus in cell culture reveals a tropism for dendritic cells and macrophages. PLoS Biol 2004; 2:e432 [View Article]
    [Google Scholar]
23. Ülper L, Sarand I, Rausalu K, Merits A. Construction, properties, and potential application of infectious plasmids containing Semliki Forest virus full-length cDNA with an inserted intron. J Virol Methods 2008; 148:265–270 [View Article]
    [Google Scholar]
24. Ferguson MC, Saul S, Fragkoudis R, Weisheit S, Cox J et al. Ability of the encephalitic arbovirus Semliki Forest virus to cross the blood-brain barrier is determined by the charge of the E2 glycoprotein. J Virol 2015; 89:7536–7549 [View Article]
    [Google Scholar]
25. Moser LA, Boylan BT, Moreira FR, Myers LJ, Svenson EL et al. Growth and adaptation of Zika virus in mammalian and mosquito cells. PLoS Negl Trop Dis 2018; 12:e0006880 [View Article]
    [Google Scholar]
26. Laverty G, Gilmore BF, Jones DS, Coyle L, Folan M et al. Antimicrobial efficacy of an innovative emulsion of medium chain triglycerides against canine and feline periodontopathogens. J Small Anim Pract 2015; 56:253–263 [View Article]
    [Google Scholar]
27. Bryden SR, Pingen M, Lefteri DA, Miltenburg J, Delang L et al. Pan-viral protection against arboviruses by activating skin macrophages at the inoculation site. Sci Transl Med 2020; 12:eaax2421 [View Article]
    [Google Scholar]
28. Li Q, Liu Q, Huang W, Li X, Wang Y. Current status on the development of pseudoviruses for enveloped viruses. Rev Med Virol 2018; 28:e1963 [View Article][PubMed]
    [Google Scholar]
29. Ruigrok RWH, Hewat EA, Wade RH. Low pH deforms the influenza virus envelope. J Virol 1992; 73:995–998 [View Article]
    [Google Scholar]
30. Hogan S, Zapotoczna M, Stevens NT, Humphreys H, O'Gara JP et al. Eradication of Staphylococcus aureus catheter-related biofilm infections using ML:8 and Citrox. Antimicrob Agents Chemother 2016; 60:5968–5975 [View Article]
    [Google Scholar]
31. McDermott FD, Folan DMA, Winter DC, Folan MA, Baird AW. Gnotobiotic Human Colon Ex Vivo . Gastroenterol Res 2015; 8:247–252 [View Article]
    [Google Scholar]
32. Jackman J, Yoon B, Cho N-J, Cho N-J. Nanotechnology formulations for antibacterial free fatty acids and monoglycerides. Molecules 2016; 21:305 [View Article]
    [Google Scholar]
33. Yoon B, Jackman J, Valle-González E, Cho N-J. Antibacterial free fatty acids and monoglycerides: biological activities, experimental testing, and therapeutic applications. Int J Mol Sci 2018; 19:1114 [View Article]
    [Google Scholar]
34. Buranasuksombat U, Kwon YJ, Turner M, Bhandari B. Influence of emulsion droplet size on antimicrobial properties. Food Sci Biotechnol 2011; 20:793–800 [View Article]
    [Google Scholar]
35. Ma Q, Davidson PM, Zhong Q. Antimicrobial properties of microemulsions formulated with essential oils, soybean oil, and Tween 80. Int J Food Microbiol 2016; 226:20–25 [View Article][PubMed]
    [Google Scholar]
36. Donsì F, Ferrari G. Essential oil nanoemulsions as antimicrobial agents in food. J Biotechnol 2016; 233:106–120 [View Article]
    [Google Scholar]
37. Thormar H, Isaacs CE, Kim KS, Brown HR. Inactivation of visna virus and other enveloped viruses by free fatty acids and monoglycerides. Ann N Y Acad Sci 1994; 724:465–471 [View Article]
    [Google Scholar]
38. Yoon BK, Jackman JA, Kim MC, Cho N-J. Spectrum of membrane morphological responses to antibacterial fatty acids and related surfactants. Langmuir 2015; 31:10223–10232 [View Article]
    [Google Scholar]
39. Yoon BK, Jackman JA, Kim MC, Sut TN, Cho N-J. Correlating membrane morphological responses with micellar aggregation behavior of Capric acid and Monocaprin. Langmuir 2017; 33:2750–2759 [View Article]
    [Google Scholar]
40. Lundblad JL, Seng RL. Inactivation of Lipid-Enveloped viruses in proteins by caprylate. Vox Sang 1991; 60:75–81 [View Article]
    [Google Scholar]
41. Lambers H, Piessens S, Bloem A, Pronk H, Finkel P. Natural skin surface pH is on average below 5, which is beneficial for its resident flora. Int J Cosmet Sci 2006; 28:359–370 [View Article]
    [Google Scholar]
42. Fischer H, Widdicombe JH. Mechanisms of acid and base secretion by the airway epithelium. J Membrane Biol 2006; 211:139–150 [View Article]
    [Google Scholar]
43. Hamel R, Dejarnac O, Wichit S, Ekchariyawat P, Neyret A et al. Biology of Zika virus infection in human skin cells. J Virol 2015; 89:8880–8896 [View Article]
    [Google Scholar]
44. Pingen M, Schmid MA, Harris E, McKimmie CS. Mosquito biting modulates skin response to virus infection. Trends Parasitol 2017; 33:645–657 [View Article]
    [Google Scholar]
45. Mühlebach MD, Mateo M, Sinn PL, Prüfer S, Uhlig KM et al. Adherens junction protein Nectin-4 is the epithelial receptor for measles virus. Nature 2011; 480:530–533 [View Article]
    [Google Scholar]
46. Proksch E. pH in nature, humans and skin. J Dermatol 2018; 45:1044–1052 [View Article]
    [Google Scholar]